Neumora Therapeutics, Inc. (NMRA) Shareholders May Have Been Affected by Fraud – Levi & Korsinsky Investigates
NEW YORK, NY / ACCESS Newswire / January 28, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Neumora Therapeutics, Inc. ("Neumora Therapeutics, Inc.") (NASDAQ:NMRA) concerning possible violations of federal securities laws. On January 2, 2025, Neumora announced its experimental depression treatment failed in the first of three studies planned […]